spawns
Heron Therapeutics (HRTX) added ~14% on Friday after the company announced its preliminary and unaudited net revenue figures for Q4 and full-year 2025, exceeding Street forecasts.
The Cary, North Carolina-based biotech said it expects its Q4 and full-year net revenue to